The European Chemical Agency has launched a new public consultation concerning six potential SVHC. Stakeholders can provide comments on these proposed SVHC until 19 October 2018. Comments will be taken into account when deciding whether the substances will be added to the ECHA Candidate List of SVHC.By Bureau Veritas Technical Services 3 minute read
On 4 September 2018, the European Chemicals Agency (ECHA) published six new potential Substances of Very High Concern (SVHC) candidates (see table). After preparing dossiers for the substances, the ECHA has now invited interested parties to a public consultation in which they can provide comments within a timeframe of 45 days (until 19 October 2018).
A decision will be made as to whether the substances will be included to the ECHA Candidate List of SVHC after the consultation.
The Six Potential SVHCs:
|Name||CAS no. (EC no.)||Reason for inclusion|
|2,2-bis(4'-hydroxyphenyl)-4-methylpentane||6807-17-6 (401-720-1)||Toxic for reproduction (Article 57c)|
Carcinogenic (Article 57a);
|Fluoranthene||206-44-0 (205-912-4)||PBT (Article 57d); vPvB (Article 57e)|
|Phenanthrene||85-01-8 (201-581-5)||vPvB (Article 57e)|
|Pyrene||129-00-0 (204-927-3)||PBT (Article 57d); vPvB (Article 57e)|
|Undecafluorohexanoic acid and its ammonium salt||307-24-4; 21615-47-4 (206-196-6; 244-479-6)||Equivalent level of concern having probable serious effects to human health and environment (Article 57f)|
The SVHC public consultation page:
How Does this Impact You? Contact Us to Discuss
Bureau Veritas offers a wide range of chemical management solutions to help you overcome the challenges of complying with the REACH Regulation. If you have any comments and/or questions, please contact your customer service representative or contact us at email@example.com.
For the best experience, please download one of our supported browsers:Ã¦Ë†â€˜Ã¤Â»Â¬Ã¦Â£â‚¬Ã¦Âµâ€¹Ã¥Ë†Â°Ã¦â€šÂ¨Ã¥Â½â€œÃ¥â€°ï¿½Ã¦â€°â‚¬Ã¤Â½Â¿Ã§â€�Â¨Ã§Å¡â€žÃ¦Âµï¿½Ã¨Â§Ë†Ã¥â„¢Â¨Ã¤Â¸ï¿½Ã¥ï¿½â€”Ã¦â€�Â¯Ã¦Å’ï¿½Ã£â‚¬â€šÃ¦â€šÂ¨Ã¥ï¿½Â¯Ã¤Â»Â¥Ã§Â»Â§Ã§Â»ÂÃ¦Âµï¿½Ã¨Â§Ë†Ã¨Â¯Â¥Ã¥Â¹Â³Ã¥ï¿½Â°Ã¯Â¼Å’Ã¤Â½â€ Ã¦Å¸ï¿½Ã¤Âºâ€ºÃ§â€°Â¹Ã¥Â¾ï¿½Ã¥â€™Å’Ã¥Å Å¸Ã¨Æ’Â½Ã¥ï¿½Â¯Ã¨Æ’Â½Ã¦â€”Â Ã¦Â³â€¢Ã¦ÂÂ£Ã¥Â¸Â¸Ã¨Â¿ï¿½Ã¨Â¡Å’Ã£â‚¬â€š